DR. ARNOLD E POSTLETHWAITE, MD
Osteopathic Medicine at Madison Ave, Memphis, TN

License number
Tennessee 16094
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
880 Madison Ave, Memphis, TN 38103
Phone
(901) 545-6969
(901) 545-4750 (Fax)
(901) 448-8015 (Fax)

Personal information

See more information about ARNOLD E POSTLETHWAITE at radaris.com
Name
Address
Phone
Arnold Postlethwaite, age 83
635 Bethany, Eads, TN 38028
(901) 277-1798
Arnold E Postlethwaite, age 83
5911 Kermit Dr, Memphis, TN 38119
Arnold E Postlethwaite, age 83
635 Bethany, Eads, TN 38028
(901) 853-1690
(304) 775-2580
Arnold E Postlethwaite, age 83
676 N Germantown Pkwy #205, Cordova, TN 38018
(901) 853-1690
Arnold E Postlethwaite, age 83
635 Bethany Rd, Collierville, TN 38017
(901) 853-1690

Organization information

See more information about ARNOLD E POSTLETHWAITE at bizstanding.com

Utmg - Arnold E Postlethwaite MD

956 Ct Ave #G326, Memphis, TN 38103

Categories:
Rheumatology Physicians & Surgeons
Phone:
(901) 448-5774 (Phone)

Professional information

See more information about ARNOLD E POSTLETHWAITE at trustoria.com
Arnold Postlethwaite Photo 1
Dr. Arnold Postlethwaite, Memphis TN - MD (Doctor of Medicine)

Dr. Arnold Postlethwaite, Memphis TN - MD (Doctor of Medicine)

Specialties:
Rheumatology
Address:
UT Medical Group RHU
880 Madison Ave, Memphis 38103
(901) 448-5774 (Phone)
Procedures:
Joint Drainage, Steroid Injections
Conditions:
Arthritis, Bursitis, Carpal Tunnel Syndrome, Chronic Neck Pain, Dermatomyositis, Fibromyalgia, Gout, Hepatitis B - Immune Response, Low Back Pain, Lupus Erythematosus, Osteoarthritis, Osteoarthritis of Hand or Wrist, Osteoarthritis of Hip, Osteoarthritis of Knee, Osteoarthritis of Spine, Osteopenia, Osteoporosis, Patellofemoral Pain Syndrome or Knee Pain, Polymyositis, Raynaud's Disease, Rheumatoid Arthritis, Sarcoidosis, Scleroderma, Sjögren's Syndrome, Spondylitis, Still's Disease, Systemic Lupus Erythematosus (SLE), Systemic Sclerosis
Certifications:
Internal Medicine, 1974, Rheumatology, 1976
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
UT Medical Group RHU
880 Madison Ave, Memphis 38103
Methodist University Hospital
1265 Union Avenue Ext, Memphis 38104
Education:
Medical School
Joan Sanford I Weill Medical College Of Cornell University
Graduated: 1966
Charity Hosp/Tulane
Graduated: 1967
Graduated: 1968
Duke University Med Center
Graduated: 1972


Arnold E Postlethwaite Photo 2
Arnold E Postlethwaite, Memphis TN

Arnold E Postlethwaite, Memphis TN

Specialties:
Rheumatologist
Address:
1910 Nonconnah Blvd, Memphis, TN 38132
956 Court Ave, Memphis, TN 38103
Education:
Cornell University, Weill Cornell Medical College - Doctor of Medicine
Duke University Hospital - Fellowship - Rheumatology (Internal Medicine)
Duke University Hospital - Residency - Family Medicine
LSU Interim Hospital - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Rheumatology (Internal Medicine)


Arnold Eugene Postlethwaite Photo 3
Arnold Eugene Postlethwaite, Memphis TN

Arnold Eugene Postlethwaite, Memphis TN

Specialties:
Internal Medicine, Rheumatology
Work:
UTMG Rheumatology
880 Madison - Medplex, Memphis, TN 38103 University of Tennessee
956 Court Ave, Memphis, TN 38163 UT Medical Group
880 Madison Ave, Memphis, TN 38103
Education:
Cornell University (1966)


Arnold Postlethwaite Photo 4
Method For Treatment Of Systemic Sclerosis And Related Fibrotic Diseases

Method For Treatment Of Systemic Sclerosis And Related Fibrotic Diseases

US Patent:
5962025, Oct 5, 1999
Filed:
Jul 16, 1996
Appl. No.:
8/682021
Inventors:
Laura Carbone - Memphis TN
Andrew H. Kang - Memphis TN
Kevin McKown - Memphis TN
Arnold E. Postlethwaite - Memphis TN
Jerome M. Seyer - Virginia Beach VA
Assignee:
The University of Tennessee Research Corporation - Knoxville TN
International Classification:
A61K 3512
US Classification:
424520
Abstract:
The present invention is directed to a method and pharmaceutical formulations for the treatment of systemic sclerosis in mammals, by oral administration of collagen, including type I collagen, or biologically active peptide fragments thereof.